New York State Common Retirement Fund
LRMR icon

New York State Common Retirement Fund’s Larimar Therapeutics LRMR Stock Holding History

New York State Common Retirement Fund’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Hold
6,619
– – ﹤0.01% 3123
2026
Q1 		$29.8K Hold
6,619
– – ﹤0.01% 2951
2025
Q4 		$25.2K Hold
6,619
– – ﹤0.01% 3053
2025
Q3 		$21.4K Hold
6,619
– – ﹤0.01% 3100
2025
Q2 		$19.1K Hold
6,619
– – ﹤0.01% 3122
2025
Q1 		$14.2K Hold
6,619
– – ﹤0.01% 3028
2024
Q4 		$25.6K Hold
6,619
– – ﹤0.01% 3000
2024
Q3 		$43.4K Hold
6,619
– – ﹤0.01% 2907
2024
Q2 		$48K Buy
6,619
+12
+0.2% +$92 ﹤0.01% 3098
2024
Q1 		$50.1K Hold
6,607
– – ﹤0.01% 2982
2023
Q4 		$30.1K Sell
6,607
-56
-0.8% -$189 ﹤0.01% 3105
2023
Q3 		$26.3K Sell
6,663
-23,137
-78% -$87.5K ﹤0.01% 3155
2023
Q2 		$93.3K Buy
+29,800
New +$122K ﹤0.01% 2916
2019
Q2 		– Sell
-2,108
Closed -$69K – 3280
2019
Q1 		$69K Sell
2,108
-1,205
-36% -$61.8K ﹤0.01% 3026
2018
Q4 		$197K Sell
3,313
-54
-2% -$5.33K ﹤0.01% 2725
2018
Q3 		$472K Buy
3,367
+1,259
+60% +$153K ﹤0.01% 2440
2018
Q2 		$259K Buy
+2,108
New +$179K ﹤0.01% 2755
2017
Q2 		– Sell
-1,333
Closed -$75K – 3214
2017
Q1 		$75K Hold
1,333
– – ﹤0.01% 3013
2016
Q4 		$51K Hold
1,333
– – ﹤0.01% 3062
2016
Q3 		$53K Hold
1,333
– – ﹤0.01% 3081
2016
Q2 		$96K Hold
1,333
– – ﹤0.01% 3005
2016
Q1 		$107K Hold
1,333
– – ﹤0.01% 2909
2015
Q4 		$101K Hold
1,333
– – ﹤0.01% 3005
2015
Q3 		$511K Buy
1,333
+158
+13% +$71.2K ﹤0.01% 2309
2015
Q2 		$488K Buy
+1,175
New +$492K ﹤0.01% 2530

Other funds holding LRMR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
NLP
Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

New York State Common Retirement Fund's LRMR Position: Q2 2026 in Review

New York State Common Retirement Fund held its Larimar Therapeutics (LRMR) position steady in Q2 2026 at 6,619 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

New York State Common Retirement Fund first reported a position in LRMR in Q2 2015 and has held it in 25 quarters since. The position peaked at $511K in Q3 2015. 29 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • New York State Common Retirement Fund held 6,619 shares of Larimar Therapeutics worth $20.2K as of Q2 2026.
  • New York State Common Retirement Fund left its Larimar Therapeutics share count unchanged in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3123 holding.
  • New York State Common Retirement Fund first reported a position in Larimar Therapeutics in Q2 2015 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's Larimar Therapeutics position peaked at $511K in Q3 2015.
  • 29 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.